Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090105186A1
SERIAL NO

11577677

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to β-L-N4-hydroxycytosine nucleo-sides, pharmaceutical agents comprising same, and to the use of said β-L-N4-hydroxycytosine nucleosides and pharmaceutical agents in the prophylaxis or therapy of an infection caused by hepatitis B virus (HBV) or human immunodeficiency virus (HIV). The invention also relates to a method for the preparation of said β-L-nucleoside analogs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN13125 BERLIN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Funk, Anneke Hamburg, DE 2 8
Matthes, Eckart Eggersdorf, DE 8 125
Sirma, Huseyin Elmshorn, DE 3 28
von, Janta-Lipinski Martin Berlin, DE 6 115
Will, Hans Hamburg, DE 8 79

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation